Page last updated: 2024-10-25

deferoxamine and Bowen Disease

deferoxamine has been researched along with Bowen Disease in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choudry, K1
Brooke, RC1
Farrar, W1
Rhodes, LE1
Fijan, S1
Hönigsmann, H1
Ortel, B1

Trials

1 trial available for deferoxamine and Bowen Disease

ArticleYear
The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
    The British journal of dermatology, 2003, Volume: 149, Issue:1

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Car

2003

Other Studies

1 other study available for deferoxamine and Bowen Disease

ArticleYear
Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine.
    The British journal of dermatology, 1995, Volume: 133, Issue:2

    Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Deferoxamine; Female; Humans; Keratosis

1995